These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 21119099)

  • 1. The role of benzalkonium chloride in the occurrence of punctate keratitis: a meta-analysis of randomized, controlled clinical trials.
    Trocme S; Hwang LJ; Bean GW; Sultan MB
    Ann Pharmacother; 2010 Dec; 44(12):1914-21. PubMed ID: 21119099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyquad-preserved travoprost/timolol, benzalkonium chloride (BAK)-preserved travoprost/timolol, and latanoprost/timolol in fixed combinations: a rabbit ocular surface study.
    Liang H; Brignole-Baudouin F; Pauly A; Riancho L; Baudouin C
    Adv Ther; 2011 Apr; 28(4):311-25. PubMed ID: 21424577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detrimental effect of preservatives in eyedrops: implications for the treatment of glaucoma.
    Baudouin C
    Acta Ophthalmol; 2008 Nov; 86(7):716-26. PubMed ID: 18537937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bandage lenses and the use of topical solutions containing preservatives.
    Lemp MA
    Ann Ophthalmol; 1978 Oct; 10(10):1319-21. PubMed ID: 718037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Toxicity research status of benzalkonium chloride on ocular surface].
    Huang C; Chen W; Chen Y; Liu Z
    Zhonghua Yan Ke Za Zhi; 2014 Apr; 50(4):303-6. PubMed ID: 24931157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anaphylaxis with use of eye-drops containing benzalkonium chloride preservative.
    Anderson D; Faltay B; Haller NA
    Clin Exp Optom; 2009 Sep; 92(5):444-6. PubMed ID: 19549228
    [No Abstract]   [Full Text] [Related]  

  • 7. Benzalkonium chloride as a preservative in nasal solutions: re-examining the data.
    Graf P
    Respir Med; 2001 Sep; 95(9):728-33. PubMed ID: 11575893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid and selective removal of preservative from ophthalmic formulations during eyedrops instillation.
    Hsu KH; Chauhan A
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):30-8. PubMed ID: 26459089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preservatives in eyedrops: the good, the bad and the ugly.
    Baudouin C; Labbé A; Liang H; Pauly A; Brignole-Baudouin F
    Prog Retin Eye Res; 2010 Jul; 29(4):312-34. PubMed ID: 20302969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of corneal and conjunctival changes after dosing of travoprost preserved with sofZia, latanoprost with 0.02% benzalkonium chloride, and preservative-free artificial tears.
    Kahook MY; Noecker RJ
    Cornea; 2008 Apr; 27(3):339-43. PubMed ID: 18362664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Structural and immunohistochemical changes of conjunctiva induced by topical glaucoma medication].
    Nenciu A; Stefan C; Ardelean C
    Oftalmologia; 2004; 48(1):35-42. PubMed ID: 15279417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular surface inflammatory changes induced by topical antiglaucoma drugs: human and animal studies.
    Baudouin C; Pisella PJ; Fillacier K; Goldschild M; Becquet F; De Saint Jean M; Béchetoille A
    Ophthalmology; 1999 Mar; 106(3):556-63. PubMed ID: 10080214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of timolol, benzalkonium-preserved timolol, and benzalkonium-preserved brimonidine on oxidative stress biomarkers in the tear film.
    Sedlak L; Wojnar W; Zych M; Wyględowska-Promieńska D
    Cutan Ocul Toxicol; 2020 Sep; 39(3):260-268. PubMed ID: 32594785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An in vivo confocal microscopy analysis of effects of topical antiglaucoma therapy with preservative on corneal innervation and morphology.
    Martone G; Frezzotti P; Tosi GM; Traversi C; Mittica V; Malandrini A; Pichierri P; Balestrazzi A; Motolese PA; Motolese I; Motolese E
    Am J Ophthalmol; 2009 Apr; 147(4):725-735.e1. PubMed ID: 19181302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of failure in glaucoma filtering surgery: a consequence of antiglaucomatous drugs?
    Baudouin C
    Int J Clin Pharmacol Res; 1996; 16(1):29-41. PubMed ID: 9001927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unilateral drug-induced ocular pseudopemphigoid.
    Gibran SK
    Eye (Lond); 2004 Dec; 18(12):1270. PubMed ID: 15044940
    [No Abstract]   [Full Text] [Related]  

  • 17. Ophthalmic preservatives: focus on polyquaternium-1.
    Rolando M; Crider JY; Kahook MY
    Expert Opin Drug Deliv; 2011 Nov; 8(11):1425-38. PubMed ID: 21905766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of preservatives on the conjunctiva: a comparative study of beta-blocker eye drops with and without preservatives in glaucoma patients].
    Pisella PJ; Lala E; Parier V; Brignole F; Baudouin C
    J Fr Ophtalmol; 2003 Sep; 26(7):675-9. PubMed ID: 13130254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of Benzalkonium Chloride in Ophthalmic Eyedrop Medications on Corneal Epithelium].
    Seino S; Takada Y; Saika S
    Yakugaku Zasshi; 2021; 141(1):35-39. PubMed ID: 33390445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multidose Preservative Free Eyedrops by Selective Removal of Benzalkonium Chloride from Ocular Formulations.
    Hsu KH; Gupta K; Nayaka H; Donthi A; Kaul S; Chauhan A
    Pharm Res; 2017 Dec; 34(12):2862-2872. PubMed ID: 29067592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.